Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania.
Health Econ. 2018 Jul;27(7):1063-1073. doi: 10.1002/hec.3651. Epub 2018 Apr 16.
As medical expenses continue to rise, methods to properly analyze cost outcomes are becoming of increasing relevance when seeking to compare average costs across treatments. Inverse probability weighted regression models have been developed to address the challenge of cost censoring in order to identify intent-to-treat effects (i.e., to compare mean costs between groups on the basis of their initial treatment assignment, irrespective of any subsequent changes to their treatment status). In this paper, we describe a nested g-computation procedure that can be used to compare mean costs between two or more time-varying treatment regimes. We highlight the relative advantages and limitations of this approach when compared with existing regression-based models. We illustrate the utility of this approach as a means to inform public policy by applying it to a simulated data example motivated by costs associated with cancer treatments. Simulations confirm that inference regarding intent-to-treat effects versus the joint causal effects estimated by the nested g-formula can lead to markedly different conclusions regarding differential costs. Therefore, it is essential to prespecify the desired target of inference when choosing between these two frameworks. The nested g-formula should be considered as a useful, complementary tool to existing methods when analyzing cost outcomes.
随着医疗费用的不断上涨,在寻求比较不同治疗方法的平均成本时,正确分析成本结果的方法变得越来越重要。为了解决成本删失的挑战,已经开发了逆概率加权回归模型,以确定意向治疗效果(即,根据初始治疗分配比较组之间的平均成本,而不考虑其治疗状态的任何后续变化)。在本文中,我们描述了一种嵌套 g 计算程序,可用于比较两种或多种随时间变化的治疗方案之间的平均成本。我们强调了与现有基于回归的模型相比,该方法的相对优势和局限性。我们通过将其应用于一个受癌症治疗相关成本驱动的模拟数据示例来说明该方法在为公共政策提供信息方面的实用性。模拟结果证实,关于意向治疗效果与嵌套 g 公式估计的联合因果效应的推断可能会导致关于差异成本的截然不同的结论。因此,在这两种框架之间进行选择时,必须预先指定所需的推断目标。在分析成本结果时,嵌套 g 公式应被视为现有方法的有用补充工具。